| Temporal Expression Analysis of the Borrelia burgdorferi Paralogous Gene Family 54 Genes BBA64, BBA65, and BBA66 during Persistent Infection in Mice RD Gilmore Jr, RR Howison, VL Schmit, AJ Nowalk, DR Clifton, C Nolder, ... Infection and immunity 75 (6), 2753-2764, 2007 | 62 | 2007 |
| Lab-on-a-bubble surface enhanced Raman indirect immunoassay for cholera VL Schmit, R Martoglio, KT Carron Analytical chemistry 84 (9), 4233-4236, 2012 | 55 | 2012 |
| Lab-on-a-bubble: synthesis, characterization, and evaluation of buoyant gold nanoparticle-coated silica spheres VL Schmit, R Martoglio, B Scott, AD Strickland, KT Carron Journal of the American Chemical Society 134 (1), 59-62, 2012 | 45 | 2012 |
| Borrelia burgdorferi Surface-Localized Proteins Expressed during Persistent Murine Infection Are Conserved among Diverse Borrelia spp JL Hughes, CL Nolder, AJ Nowalk, DR Clifton, RR Howison, VL Schmit, ... Infection and immunity 76 (6), 2498-2511, 2008 | 40 | 2008 |
| Borrelia burgdorferi expression of the bba64, bba65, bba66, and bba73 genes in tissues during persistent infection in mice RD Gilmore Jr, RR Howison, VL Schmit, JA Carroll Microbial pathogenesis 45 (5-6), 355-360, 2008 | 38 | 2008 |
| Global Transcriptome Analysis of Borrelia burgdorferi during Association with Human Neuroglial Cells JA Livengood, VL Schmit, RD Gilmore Jr Infection and immunity 76 (1), 298-307, 2008 | 29 | 2008 |
| Exploring risks of human challenge trials for COVID‐19 D Manheim, W Wiȩcek, V Schmit, J Morrison, ... Risk Analysis 41 (5), 710-720, 2021 | 27 | 2021 |
| Analysis of Borrelia burgdorferi Surface Proteins as Determinants in Establishing Host Cell Interactions VL Schmit, TG Patton, RD Gilmore Jr Frontiers in microbiology 2, 141, 2011 | 24 | 2011 |
| A systematic review of human challenge trials, designs, and safety J Adams-Phipps, D Toomey, W Więcek, V Schmit, J Wilkinson, K Scholl, ... Clinical Infectious Diseases 76 (4), 609-619, 2023 | 22 | 2023 |
| Wild felids as hosts for human plague, Western United States SN Bevins, JA Tracey, SP Franklin, VL Schmit, ML MacMillan, KL Gage, ... Emerging Infectious Diseases 15 (12), 2021, 2009 | 20 | 2009 |
| Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials SM Rose, VL Schmit, TC Darton, N Eyal, M Magalhaes, J Morrison, ... medRxiv, 2021.03. 14.21253548, 2021 | 7 | 2021 |
| Considering human challenge trials for tuberculosis vaccine development G Kleinwaks, V Schmit, J Morrison Vaccine 40 (2), 173-174, 2022 | 5 | 2022 |
| Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials AA Marsh, M Magalhaes, M Peeler, SM Rose, TC Darton, N Eyal, ... PloS one 17 (11), e0275823, 2022 | 4 | 2022 |
| Managing the transition to widespread metagenomic monitoring: policy considerations for future biosurveillance C Liang, J Wagstaff, N Aharony, V Schmit, D Manheim Health security 21 (1), 34-45, 2023 | 2 | 2023 |
| Lab-on-a-bubble: direct and indirect assays with portable Raman instrumentation K Carron, V Schmit, B Scott, R Martoglio Optics and Photonics for Counterterrorism, Crime Fighting, and Defence VIII …, 2012 | 1 | 2012 |
| 7 Human Challenge Trials for Research on COVID-19 and Beyond J Adams-Phipps, S Kamenicek, V Schmit Behavioural Economics and Policy for Pandemics: Insights from Responses to …, 2024 | | 2024 |
| Ethical Acceptability of Human Challenge Trials: Consultation With the US Public and With Research Personnel J Elsey, D Manheim, A Marsh, V Schmit, D Moss PsyArXiv, 2023 | | 2023 |
| Corrigendum to" Considering human challenge trials for tuberculosis vaccine development"[Vaccine 40 (2)(2022) 173-174]. G Kleinwaks, V Schmit, J Morrison Vaccine 40 (29), 3984-3984, 2022 | | 2022 |
| Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials (preprint) SM Rose, VL Schmit, TC Darton, N Eyal, M Magalhaes, J Morrison, ... | | 2021 |
| Exploring Risks of Human Challenge Trials for COVID-19 (preprint) D Manheim, W Wiecek, V Schmit, J Morrison | | 2020 |
